Physician profile
Norma D Mobley
NPI 1568407856
$1,857.15
in general payments reported to CMS, 2019-2025
19 companies · $106 in 2025
The $106 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $98.54 · 2021: $220 · 2022: $300 · 2023: $408 · 2024: $505 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $451.50 | 2021-2024 | Qelbree, Qelbree |
| Corium, LLC | $407.34 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $292.99 | 2019-2024 | Jornay Pm |
| Cumberland Pharmaceuticals, INC. | $145.80 | 2019-2024 | Kristalose |
| Merck Sharp & Dohme LLC | $107.58 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Genentech USA, INC. | $64.33 | 2024 | Xolair |
| Pfizer INC. | $59.81 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.02 | 2020-2022 | |
| Sanofi Pasteur INC. | $50.18 | 2023-2024 | |
| Rhythm Pharmaceuticals, INC. | $36.30 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $28.44 | 2023 | |
| Biomerieux INC | $27.33 | 2023 | |
| Glaxosmithkline, LLC. | $24.99 | 2019-2023 | Bexsero, Pediarix |
| Sanofi-Aventis U.S. LLC | $24.98 | 2025 | |
| Vertical Pharmaceuticals, LLC | $18.68 | 2025 | Relexxii |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $17.40 | 2019 | |
| Nestle Healthcare Nutrition INC. | $17.26 | 2021 | |
| Adlon Therapeutics L.P. | $16.35 | 2020 | |
| Neos Therapeutics, LP | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Mobley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.